CNTN · Canton Strategic Holdings, Inc. · Insider Trading

Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock upon vesting, without payment of an exercise price.

Represents the time-based portion of a restricted stock unit award granted to the reporting person on October 23, 2026 under the Tharimmune, Inc. Amended and Restated 2023 Omnibus Equity Incentive Plan, as amended. Subject to the reporting person's continued employment through each vesting date, 25% of these restricted stock units vest on November 6, 2026, and the remaining 75% vest in twelve equal quarterly installments over the following 36 months.

The restricted stock units do not have an expiration date. Vested restricted stock units will be settled in shares of the Issuer's common stock.

This option was issued to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy as an annual director equity grant.

Grant of option to purchase Common Stock under the Issuer's Amended and Restated 2023 Omnibus Equity Incentive Plan. Of the shares subject to the option, (i) 13,440 shares were vested as of October 23, 2026, (ii) 13,441 shares shall vest on January 11, 2027, (iii) 13,441 shares shall vest on April 12, 2027, and (iv) the remaining 13,441 shares shall vest on July 13, 2027, in each case subject to the Reporting Person's continuous service as a member of the Issuer's board of directors immediately prior to the applicable vesting date.

This option was issued to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy as an annual director equity grant.

Grant of option to purchase Common Stock under the Issuer's Amended and Restated 2023 Omnibus Equity Incentive Plan. Of the shares subject to the option, (i) 13,440 shares were vested as of October 23, 2026, (ii) 13,441 shares shall vest on January 11, 2027, (iii) 13,441 shares shall vest on April 12, 2027, and (iv) the remaining 13,441 shares shall vest on July 13, 2027, in each case subject to the Reporting Person's continuous service as a member of the Issuer's board of directors immediately prior to the applicable vesting date.

Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock upon vesting, without payment of an exercise price.

Represents the time-based portion of a restricted stock unit award granted to the reporting person on October 23, 2026 under the Tharimmune, Inc. Amended and Restated 2023 Omnibus Equity Incentive Plan, as amended. Subject to the reporting person's continued employment through each vesting date, 25% of these restricted stock units vest on November 6, 2026, and the remaining 75% vest in twelve equal quarterly installments over the following 36 months.

The restricted stock units do not have an expiration date. Vested restricted stock units will be settled in shares of the Issuer's common stock.

This option was issued to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy as an annual director equity grant.

Grant of option to purchase Common Stock under the Issuer's Amended and Restated 2023 Omnibus Equity Incentive Plan. Of the shares subject to the option, (i) 26,881 shares were vested as of October 23, 2026, (ii) 13,441 shares shall vest on November 1, 2026, and (iii) the remaining 13,441 shares shall vest on February 1, 2027, in each case subject to the Reporting Person's continuous service as a member of the Issuer's board of directors immediately prior to the applicable vesting date.

This option was issued to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy as an annual director equity grant.

Grant of option to purchase Common Stock under the Issuer's Amended and Restated 2023 Omnibus Equity Incentive Plan. Of the shares subject to the option, (i) 26,881 shares were vested as of October 23, 2026, (ii) 13,441 shares shall vest on November 1, 2026, and (iii) the remaining 13,441 shares shall vest on February 1, 2027, in each case subject to the Reporting Person's continuous service as a member of the Issuer's board of directors immediately prior to the applicable vesting date.

This option was issued to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy as an annual director equity grant.

Grant of option to purchase Common Stock under the Issuer's Amended and Restated 2023 Omnibus Equity Incentive Plan. Of the shares subject to the option, (i) 40,322 shares shall vest on October 23, 2026, and (ii) the remaining 13,441 shares shall vest on January 1, 2027, in each case subject to the Reporting Person's continuous service as a member of the Issuer's board of directors immediately prior to the applicable vesting date.

This option was issued to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy as an annual director equity grant.

Grant of option to purchase Common Stock under the Issuer's Amended and Restated 2023 Omnibus Equity Incentive Plan. Of the shares subject to the option, (i) 13,440 shares were vested as of October 23, 2026, (ii) 13,441 shares shall vest on January 11, 2027, (iii) 13,441 shares shall vest on April 12, 2027, and (iv) the remaining 13,441 shares shall vest on July 13, 2027, in each case subject to the Reporting Person's continuous service as a member of the Issuer's board of directors immediately prior to the applicable vesting date.

Gravitas Capital LP is a Delaware limited partnership whose sole general partner is Gravitas Capital Partners LLC. The managing member of Gravitas Partners LLC is Vincent S. LoPriore. As a result, Gravitas Capital LP is deemed to be the indirect owner of the securities held directly by Vincent S. LoPriore. Despite such shared beneficial ownership, the reporting persons disclaim that they constitute a statutory group within the meaning of Rule 13d-5(b) (1) of the Securities Exchange Act of 1934

45,000 of the stock options vest on date of grant and 45,000 vest on August 4, 2026.

25,000 of the stock options vest on date of grant and 25,000 vest on August 4, 2026.

Common stock issued pursuant to the Tharimmune, Inc. 2023 Omnibus Equity Incentive Plan.

On January 13, 2025, the Reporting Person was granted options ("Options") to purchase up to 52,875s shares of the Registrant's common stock pursuant to the Registrant's 2023 Omnibus Equity Incentive Plan. The Options vested in full upon grant.

On January 13, 2025, the Reporting Person was granted options ("Options") to purchase up to 80,958 shares of the Registrant's common stock pursuant to the Registrant's 2023 Omnibus Equity Incentive Plan. The Options vested in full upon grant.

On August 9, 2024, the Reporting Person was granted options ("Options") to purchase up to 2,353 shares of the Registrant's common stock pursuant to the Registrant's 2023 Omnibus Equity Incentive Plan. The Options vest in 12 equal monthly installments with the first installment vesting on the date of grant.

On August 9, 2024, the Reporting Person was granted options ("Options") to purchase up to 2,353 shares of the Registrant's common stock pursuant to the Registrant's 2023 Omnibus Equity Incentive Plan. The Options vest in 12 equal monthly installments with the first installment vesting on the date of grant.

On August 9, 2024, the Reporting Person was granted options ("Options") to purchase up to 57,707 shares of the Registrant's common stock pursuant to the Registrant's 2023 Omnibus Equity Incentive Plan. The Options vest in 12 equal monthly installments with the first installment vesting on the date of grant.

On August 9, 2024, the Reporting Person was granted options ("Options") to purchase up to 38,087 shares of the Registrant's common stock pursuant to the Registrant's 2023 Omnibus Equity Incentive Plan. The Options vest in 12 equal monthly installments with the first installment vesting on the date of grant.

On August 9, 2024, the Reporting Person was granted options ("Options") to purchase up to 2,353 shares of the Registrant's common stock pursuant to the Registrant's 2023 Omnibus Equity Incentive Plan. The Options vest in 12 equal monthly installments with the first installment vesting on the date of grant.

On November 7, 2023, the Reporting Person was granted options ("Options") to purchase up to 25,000 shares of the Registrant's common stock pursuant to the Registrant's 2023 Omnibus Equity Incentive Plan. The Options vest in 12 equal monthly installments with the first installment vesting on the date of grant.

On November 7, 2023, the Reporting Person was granted options ("Options") to purchase up to 25,000 shares of the Registrant's common stock pursuant to the Registrant's 2023 Omnibus Equity Incentive Plan. The Options vest in 12 equal monthly installments with the first installment vesting on the date of grant.

On November 7, 2023, the Reporting Person was granted options ("Options") to purchase up to 50,000 shares of the Registrant's common stock pursuant to the Registrant's 2023 Omnibus Equity Incentive Plan. The Options vest in 12 equal monthly installments with the first installment vesting on the date of grant.